Publications Breadcrumb Home Publications Since we carefully research publications with DZIF affiliation before posting them on the DZIF website, there is usually a delay of two to three months between a paper's publication date and its listing on the DZIF publications website. Show filterHide filter All years of publication All years of publication20122013201420152016201720182019202020212022202320242025 All research areas All research areasCommunity-Acquired Infections at Mucosal InterfacesHepatitisHIVInfections of the Immunocompromised HostHealthcare-Associated InfectionsMalaria and Neglected Tropical DiseasesEmerging InfectionsNovel AntibioticsTuberculosis All infrastructures All infrastructuresBioresources, Biodata and Digital HealthDZIF AcademyClinical Trial UnitProduct Development Unit Mar 2025 Int J Tuberc Lung Dis Drug susceptibility testing for TB using the Xpert MTB/XDR assay on stool specimens Autoren Khumalo W et al. Mar 2025 Cell Host Microbe Highly potent quinoxalinediones inhibit α-hemolysin and ameliorate Staphylococcus aureus lung infections Autoren Shekhar A et al. Mar 2025 PLOS Glob Public Health Prediction models for Mtb infection among adolescent and adult household contacts in high tuberculosis incidence settings Autoren Marambire ET et al. Mar 2025 BMC Med tesG expression as a potential clinical biomarker for chronic Pseudomonas aeruginosa pulmonary biofilm infections Autoren Wannigama DL et al. Mar 2025 J Med Chem From Bones to Bugs: Structure-Based Development of Raloxifene-Derived Pathoblockers That Inhibit Pyocyanin Production in Pseudomonas aeruginosa Autoren Thiemann M et al. Mar 2025 Mol Ther A precision medicine approach to primary immunodeficiency disease: Ataluren strikes nonsense mutations once again Autoren Lentini L et al. Mar 2025 Lancet Microbe Performance of stool Xpert MTB/RIF Ultra for detection of Mycobacterium tuberculosis among adults living with HIV: a multicentre, prospective diagnostic study Autoren Kasule GW et al. Mar 2025 J Antimicrob Chemother Population pharmacokinetics and exposure-response relationship of the antituberculosis drug BTZ-043 Autoren Koele SE et al. Mar 2025 Blood Res Seroprevalence of SARS-CoV-2 antibodies in patients with hematological and oncological diseases in early 2024 Autoren Cremer LM et al. Mar 2025 Sci Rep Therapeutic treatment of hepatitis E virus infection in pigs with a neutralizing monoclonal antibody Autoren Hrabal I et al. Mar 2025 Biomed Pharmacother Antimicrobial and anticancer activity of Streptomyces ambofaciens (Myt 8) and S. globisporus ONU 1019 (Myt 11) secondary metabolites isolated from the Odesa Bay, the Black Sea: An in vitro study Autoren Potapenko K et al. Mar 2025 Sci Rep Design and evaluation of a poly-epitope based vaccine for the induction of influenza A virus cross-reactive CD8 + T cell responses Autoren Dam S et al. Mar 2025 Nature A coronavirus assembly inhibitor that targets the viral membrane protein Autoren Laporte M et al. Mar 2025 Lancet Glob Health Predicted dolutegravir resistance in people living with HIV in South Africa during 2020-35: a modelling study Autoren Loosli T et al. Mar 2025 Blood Adv Characteristics of infections after BCMA-directed CAR T-cell therapy for multiple myeloma: a real-world analysis Autoren Richardson T et al. Mar 2025 Virology MyosinVb tail inhibits transport of Marburg virus glycoprotein GP to VP40-enriched sites at the plasma membrane Autoren Halwe S et al. Mar 2025 Clin Infect Dis Next-Generation Urinary LAM Assays-Are We There Yet? Autoren Gupta-Wright A et al. Mar 2025 Mol Syst Biol Persistent epigenetic memory of SARS-CoV-2 mRNA vaccination in monocyte-derived macrophages Autoren Simonis A et al. Mar 2025 J Med Chem Uncovering α-Selectivity for Liver X Receptor Agonists for Lipotoxic Cancer Therapies Autoren Galvez BPJ et al. Mar 2025 Lancet Child Adolesc Health Leveraging nutritional rehabilitation and tuberculosis programmes to tackle tuberculosis and severe acute malnutrition in children Autoren Vonasek BJ et al. Mar 2025 Clin Microbiol Infect ORCHESTRA Delphi consensus: diagnostic and therapeutic management of SARS-CoV-2 infection in haematological patients Autoren Canziani LM et al. Mar 2025 Lancet Respir Med Post-tuberculosis lung disease: towards prevention, diagnosis, and care Autoren Meghji J et al. Mar 2025 Cancer Commun Deletion of epithelial HKDC1 decelerates cellular proliferation and impairs mitochondrial function of tumorous epithelial cells thereby protecting from intestinal carcinogenesis Autoren Järke L et al. Mar 2025 Clin Microbiol Infect The non-artemisinin antimalarial drugs under development: a review Autoren Okwu DG et al. Mar 2025 Exp Hematol Oncol All-in-one CRISPR/Cas-engineered glucocorticoid-receptor knock-out EBV-gp350-CAR knock-in T cells are potent and resistant to dexamethasone Autoren Kaeuferle T et al. Pagination Previous page ‹‹ Seite 1 Seite 2 Seite 3 Seite 4 Current page 5 Seite 6 Seite 7 Seite 8 Seite 9 Seite 1 Seite 2 Seite 3 Seite 4 Seite 5 Seite 6 Seite 7 Seite 8 Seite 9 Next page ››
Mar 2025 Int J Tuberc Lung Dis Drug susceptibility testing for TB using the Xpert MTB/XDR assay on stool specimens Autoren Khumalo W et al.
Mar 2025 Cell Host Microbe Highly potent quinoxalinediones inhibit α-hemolysin and ameliorate Staphylococcus aureus lung infections Autoren Shekhar A et al.
Mar 2025 PLOS Glob Public Health Prediction models for Mtb infection among adolescent and adult household contacts in high tuberculosis incidence settings Autoren Marambire ET et al.
Mar 2025 BMC Med tesG expression as a potential clinical biomarker for chronic Pseudomonas aeruginosa pulmonary biofilm infections Autoren Wannigama DL et al.
Mar 2025 J Med Chem From Bones to Bugs: Structure-Based Development of Raloxifene-Derived Pathoblockers That Inhibit Pyocyanin Production in Pseudomonas aeruginosa Autoren Thiemann M et al.
Mar 2025 Mol Ther A precision medicine approach to primary immunodeficiency disease: Ataluren strikes nonsense mutations once again Autoren Lentini L et al.
Mar 2025 Lancet Microbe Performance of stool Xpert MTB/RIF Ultra for detection of Mycobacterium tuberculosis among adults living with HIV: a multicentre, prospective diagnostic study Autoren Kasule GW et al.
Mar 2025 J Antimicrob Chemother Population pharmacokinetics and exposure-response relationship of the antituberculosis drug BTZ-043 Autoren Koele SE et al.
Mar 2025 Blood Res Seroprevalence of SARS-CoV-2 antibodies in patients with hematological and oncological diseases in early 2024 Autoren Cremer LM et al.
Mar 2025 Sci Rep Therapeutic treatment of hepatitis E virus infection in pigs with a neutralizing monoclonal antibody Autoren Hrabal I et al.
Mar 2025 Biomed Pharmacother Antimicrobial and anticancer activity of Streptomyces ambofaciens (Myt 8) and S. globisporus ONU 1019 (Myt 11) secondary metabolites isolated from the Odesa Bay, the Black Sea: An in vitro study Autoren Potapenko K et al.
Mar 2025 Sci Rep Design and evaluation of a poly-epitope based vaccine for the induction of influenza A virus cross-reactive CD8 + T cell responses Autoren Dam S et al.
Mar 2025 Nature A coronavirus assembly inhibitor that targets the viral membrane protein Autoren Laporte M et al.
Mar 2025 Lancet Glob Health Predicted dolutegravir resistance in people living with HIV in South Africa during 2020-35: a modelling study Autoren Loosli T et al.
Mar 2025 Blood Adv Characteristics of infections after BCMA-directed CAR T-cell therapy for multiple myeloma: a real-world analysis Autoren Richardson T et al.
Mar 2025 Virology MyosinVb tail inhibits transport of Marburg virus glycoprotein GP to VP40-enriched sites at the plasma membrane Autoren Halwe S et al.
Mar 2025 Clin Infect Dis Next-Generation Urinary LAM Assays-Are We There Yet? Autoren Gupta-Wright A et al.
Mar 2025 Mol Syst Biol Persistent epigenetic memory of SARS-CoV-2 mRNA vaccination in monocyte-derived macrophages Autoren Simonis A et al.
Mar 2025 J Med Chem Uncovering α-Selectivity for Liver X Receptor Agonists for Lipotoxic Cancer Therapies Autoren Galvez BPJ et al.
Mar 2025 Lancet Child Adolesc Health Leveraging nutritional rehabilitation and tuberculosis programmes to tackle tuberculosis and severe acute malnutrition in children Autoren Vonasek BJ et al.
Mar 2025 Clin Microbiol Infect ORCHESTRA Delphi consensus: diagnostic and therapeutic management of SARS-CoV-2 infection in haematological patients Autoren Canziani LM et al.
Mar 2025 Lancet Respir Med Post-tuberculosis lung disease: towards prevention, diagnosis, and care Autoren Meghji J et al.
Mar 2025 Cancer Commun Deletion of epithelial HKDC1 decelerates cellular proliferation and impairs mitochondrial function of tumorous epithelial cells thereby protecting from intestinal carcinogenesis Autoren Järke L et al.
Mar 2025 Clin Microbiol Infect The non-artemisinin antimalarial drugs under development: a review Autoren Okwu DG et al.
Mar 2025 Exp Hematol Oncol All-in-one CRISPR/Cas-engineered glucocorticoid-receptor knock-out EBV-gp350-CAR knock-in T cells are potent and resistant to dexamethasone Autoren Kaeuferle T et al.
